RUNX1 and acute myeloid leukemia: The discovery of RUNX1 silencer R1RE15 resulted from characterisation of a novel t(5;21)(q13;q22) translocation involving RUNX1 that was acquired during the progression of myelodysplastic syndrome to AML in a paediatric patient [28].